Benvenuti sul sito web di Farmacovigilanza

Feed rss AIFA: Notizia

04/09/2026

Ordine del giorno riunione Commissione Scientifica e Economica del Farmaco (CSE)

Ultime notizie

01/06/2026

Sicurezza delle terapie avanzate per la malattia di Chron

Biblioteca Virtuale per la Salute – Piemonte

29/07/2026

Newsletter Promozione della Salute – Dors, luglio 2026

Agendas and minutes

03/09/2026

Minutes of PRAC meeting on 8-11 June 2026

Consumer Updates RSS Feed

31/08/2026

Colored and Decorative Contact Lenses: A Prescription Is A Must

Regulatory and procedural guidelines (human and veterinary)

03/09/2026

EudraVigilance - European database of suspected adverse reactions related to medicines: user manual for online access via the adrreports.eu portal

Paediatric investigation plans

04/09/2026

Opinion/decision on a Paediatric investigation plan (PIP): Skyclarys, omaveloxolone, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Congenital, familial and genetic disorders, PIP number: EMA/PE/0000338563

Orphan designations

26/08/2026

Orphan designation: daratumumab Treatment of AL amyloidosis, 25/05/2018 Withdrawn

New medicines and opinions: human

13/08/2026

Human medicines European public assessment report (EPAR): KemSu, sufentanil,ketamine, Status: Opinion under re-examination

MedWatch Safety Alerts RSS Feed

03/09/2026

Early Alert: Breathing Circuit Issue from Draeger

What's New: Drugs RSS Feed

04/09/2026

What's New Related to Drugs

FDA Drug Safety Podcasts

02/01/2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis